National Kidney Foundation

The National Kidney Foundation Honors Dr. Ana Ricardo with Distinguished Service Award

Retrieved on: 
星期三, 四月 12, 2023
Volunteering, University, Diet, Chronic kidney disease, Diabetes, Education, Kidney disease, Health, Nephrology, Research fellow, Michael Reese Hospital, Sleep, Research, UIC, Risk, Pontifical Xavierian University, Transplant, Hypertension, Public health, MD, Patient, NKF, Medical Center, Internal medicine, University of Illinois Urbana-Champaign, National Kidney Foundation, Conditional sentence, Diabetic nephropathy, Smoking, CKD, Nursing, Pharmaceutical industry, Dietary supplement, Science, Epidemiology

NEW YORK, April 12, 2023 /PRNewswire/ -- University of Illinois at Chicago (UIC) nephrologist Ana Ricardo, MD, will receive the National Kidney Foundation (NKF) Medical Advisory Board Distinguished Service Award, which recognizes individuals for their educational activities and community service in promoting the mission of NKF on a local level.

Key Points: 
  • NEW YORK, April 12, 2023 /PRNewswire/ -- University of Illinois at Chicago (UIC) nephrologist Ana Ricardo, MD, will receive the National Kidney Foundation (NKF) Medical Advisory Board Distinguished Service Award, which recognizes individuals for their educational activities and community service in promoting the mission of NKF on a local level.
  • Further, her research is focused on health disparities and health behaviors in chronic kidney disease (CKD).
  • Dr. Ricardo is also a committed volunteer for the KidneyMobile® screening program, which screens for kidney disease and risk factors including diabetes and hypertension.
  • "We need to spread the word that a great proportion of kidney disease is preventable," Dr. Ricardo said.

Akebia Therapeutics Announces Poster Presentations at National Kidney Foundation Spring Clinical Meetings 2023

Retrieved on: 
星期五, 四月 7, 2023
National Kidney Foundation, AKBA, Therapy, NKF, Kidney disease, Pharmaceutical industry

CAMBRIDGE, Mass., April 7, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present posters at the National Kidney Foundation (NKF) Spring Clinical Meetings 2023 (SCM23), which will take place on demand and live in Austin, Texas on April 11 – 15, 2023.

Key Points: 
  • CAMBRIDGE, Mass., April 7, 2023 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it will present posters at the National Kidney Foundation (NKF) Spring Clinical Meetings 2023 (SCM23), which will take place on demand and live in Austin, Texas on April 11 – 15, 2023.

The National Kidney Foundation Honors Utah Nephrologist, Researcher with Prestigious Award

Retrieved on: 
星期四, 四月 6, 2023
National Kidney Foundation, Interim, University, Chronic kidney disease, Education, Centers for Medicare & Medicaid Services, Kidney disease, International Society of Nephrology, Cardiovascular disease, Biomedical Research, American Society of Nephrology, Coronavirus Scientific Advisory Board, Research, Medicine, Science, Dialysis Patient Citizens, Hypertension, MSCE, Medicare, Kidney, Journal, Patient, Guideline, NKF, Division, Internal medicine, International Society, Weldon Humble, Humanism, Blood pressure, JASN, Society, Dialysis, SPRINT, Nursing, Pharmaceutical industry, Nephrology, MD

The award will be presented at the NKF Spring Clinical Meetings in Austin, TX this month.

Key Points: 
  • The award will be presented at the NKF Spring Clinical Meetings in Austin, TX this month.
  • I am very surprised, humbled and appreciative of this tremendous honor to receive the prestigious Hume award.
  • His research has focused on chronic kidney disease, hemodialysis, vascular access and hypertension.
  • It is the only conference of its kind that focuses on translating science into practice for the entire healthcare team.

Somatus to Present Methods for Overcoming Social Determinants of Health at the National Kidney Foundation Spring Clinical Conference

Retrieved on: 
星期四, 四月 6, 2023
National Kidney Foundation, RN, United front, Quality of life, Health, Senior, Patient, Conference, NKF, Kidney disease, Nursing

MCLEAN, Va., April 6, 2023 /PRNewswire/ -- Somatus, the nation's leading and largest value-based kidney care company, will deliver a presentation entitled "A United Front – Serving the Underserved Together" at the National Kidney (NKF) Foundation Spring Clinical Conference April 11-15, 2023. The presentation will detail the methods and successes of Somatus' patient-centric care model in the treatment of patients living with kidney disease.

Key Points: 
  • MCLEAN, Va., April 6, 2023 /PRNewswire/ -- Somatus , the nation's leading and largest value-based kidney care company, will deliver a presentation entitled "A United Front – Serving the Underserved Together" at the National Kidney (NKF) Foundation Spring Clinical Conference April 11-15, 2023.
  • The presentation will detail the methods and successes of Somatus' patient-centric care model in the treatment of patients living with kidney disease.
  • Joining Dr. Mikhael will be fellow Somatus colleagues Patrick Covington, RN, Director, Provider Engagement; Jenna Mossner, Licensed Clinical Social Worker, and Darryl Reece, Patient Health Advocate.
  • "Our presentation truly captures the impact of Somatus' patient-first, precise, and customized care approach for patients with kidney disease," said Dr. Joe Kimura, Chief Medical Officer at Somatus.

National Kidney Foundation Appoints Vizient, Inc. Executive to National Board of Directors

Retrieved on: 
星期三, 四月 5, 2023
United Nations Foundation, Workforce, Learning, NCUA, Minority, Left–right political spectrum, Vizient, Inc., Kidney failure, Senior, Prune belly syndrome, Howard University School of Law, George Mason University, Advisory board, Consumer Protection Act, National Credit Union Administration, NKF, National Kidney Foundation, Kidney, Law, DEI, SVP, Woman, Provisions of the Dodd–Frank Wall Street Reform and Consumer Protection Act, National Board of Trial Advocacy, Kidney disease, Management, Nursing

NEW YORK, April 5, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF) is thrilled to announce the appointment of Monica Davy, Senior Vice President and Chief Culture, Diversity, and Impact Officer at Vizient, Inc., to its National Board of Directors. Davy was nominated and approved at NKF's most recent Board meeting held in April.

Key Points: 
  • NEW YORK, April 5, 2023 /PRNewswire/ -- The National Kidney Foundation (NKF) is thrilled to announce the appointment of Monica Davy , Senior Vice President and Chief Culture, Diversity, and Impact Officer at Vizient, Inc., to its National Board of Directors.
  • I'm honored to join NKF's National Board and share my expertise with the largest kidney organization in the country!
  • "We're so excited Monica has joined the NKF Board of Directors and will bring her extensive expertise in DEI initiatives to the Board," said Tracy McKibben, Chair of NKF's National Board and a living kidney donor to her mother.
  • We look forward to working with her as we continue to build greater awareness of kidney disease and ways to achieve optimal kidney health."

Element Apothec Launches Full Suite of Cannabinoid and Other Integrative Health Education Initiatives

Retrieved on: 
星期三, 四月 5, 2023
Alternative medicine, ECS, Health, Cannabinoid, American Psychiatric Association, Blog, History, Terpene, Limonene, Science, Organization, CBN, Cannabinol, Drug, Physician, Cannabis, National Kidney Foundation, Medical cannabis, Entrepreneurship, Conference, Social media, Cannabidiol, Wellness, Nursing, Online shopping, CBD

WOODLAND HILLS, Calif., April 5, 2023 /PRNewswire/ -- Element Apothec, a purpose-driven wellness and beauty company, announced enhancements to their integrative health and wellness education efforts through the launch of a new suite of services, including a cannabinoid certification course and personalized consultation services.

Key Points: 
  • WOODLAND HILLS, Calif., April 5, 2023 /PRNewswire/ -- Element Apothec , a purpose-driven wellness and beauty company, announced enhancements to their integrative health and wellness education efforts through the launch of a new suite of services, including a cannabinoid certification course and personalized consultation services.
  • As a thought leader in the space, Element Apothec is providing additional tools and resources on these important topics.
  • In collaboration with the Medical Cannabis Mentor educational platform, Element Apothec launched the CBD for Health & Wellness certification course.
  • In addition to the consultations, Element Apothec offers other consumer focused education opportunities through their website and social media.

EmblemHealth Brings Diabetes and Kidney Disease Awareness Education to New Yorkers

Retrieved on: 
星期二, 四月 4, 2023
Mental Hygiene, Heart, Nutrition, ARB, Kidney failure, Food, Chronic kidney disease, Diabetes, Prevalence, Partners for Community Impact, Glucose, Physician, Stroke, Eating, Advocate, EmblemHealth, Risk, Vegetable, SGLT2, Dietary fiber, Committee, National Kidney Foundation of Michigan, New Yorker, Public health, Kidney, Walking, New York City Council, ACE, Greater New York, National Kidney Foundation, MPV, New York City Department of Health and Mental Hygiene, Exercise, CKD, Town hall, Kidney disease, Nursing, Dietary supplement, Pharmaceutical industry, Health, City, Endocrinology

NEW YORK, April 3, 2023 /PRNewswire/ -- One in three adults with diabetes could have kidney disease. To further educate the public on preventing and managing complications related to diabetes and kidney disease, as well as advise New Yorkers on ways to advocate for themselves and their loved ones, EmblemHealth, one of the nation's largest nonprofit health insurers, partnered with healthcare stakeholders on March 28 for an informational webinar titled Diabetes and Kidney Disease: How to Manage, Cope, and Advocate for Yourself. 

Key Points: 
  • City Council Health Committee Chair, NYC Health Commissioner, and National Kidney Foundation join EmblemHealth's Public Health Education Series
    NEW YORK, April 3, 2023 /PRNewswire/ -- One in three adults with diabetes could have kidney disease .
  • Diabetes continues to be the leading cause of a variety of health conditions such as heart disease, stroke, and kidney disease.
  • "Diabetes is a top risk factor for kidney disease.
  • Preventing chronic kidney disease and kidney failure start with ongoing conversations on managing current chronic conditions," said Beth Leonard, EmblemHealth Chief Corporate Affairs Officer.

Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results

Retrieved on: 
星期四, 三月 30, 2023
Insurance, LSE, Telephone, Calendar, Prescription, Research, SALT, SGLT2, EDT, Community health, PIN, Patient, Wake Forest, Nurse practitioner, National Kidney Foundation, FDA, American Diabetes Association, Society, Kidney disease, BST, Medical device, Nursing, Pharmaceutical industry, Cryptocurrency, University of Pennsylvania

LONDON and SALT LAKE CITY, March 30, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the fiscal second quarter and first half ended December 31, 2022.

Key Points: 
  • LONDON and SALT LAKE CITY, March 30, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the fiscal second quarter and first half ended December 31, 2022.
  • Cost of revenue for the three months ended December 31, 2022 was $0.7 million (Q1 FY22: $0.5 million).
  • Operating expense for the three months ended December 31, 2022 was $10.1 million compared with $14.1 million during the prior year period.
  • Upon registering, a dial-in number and unique PIN will be provided in order for interested parties to join the conference call.

The National Kidney Foundation Honors Pediatric Nurse with Prestigious Carol Mattix Award

Retrieved on: 
星期三, 三月 29, 2023
Kidney failure, CDN, Clinic, Education, Peritoneal dialysis, National Kidney Foundation, Rachel Wammack, Research, Baptist Memorial Hospital, Dialysis, Kidney disease, Science, MSCE, Nephrology, Patient, NKF, Arkansas Children's Hospital, Council, RN, Hospital, Nursing, Health insurance, MD

NEW YORK, March 29, 2023 /PRNewswire/ -- In April, the National Kidney Foundation (NKF) will honor pediatric nurse Jeanetta Wammack , RN, CDN for her dedication as a Peritoneal Dialysis Nurse at Arkansas Children's Hospital by presenting her with the Council of Nephrology Nurses and Technicians award in the name of Carol Mattix.

Key Points: 
  • NEW YORK, March 29, 2023 /PRNewswire/ -- In April, the National Kidney Foundation (NKF) will honor pediatric nurse Jeanetta Wammack , RN, CDN for her dedication as a Peritoneal Dialysis Nurse at Arkansas Children's Hospital by presenting her with the Council of Nephrology Nurses and Technicians award in the name of Carol Mattix.
  • "Jeanetta's devotion to her patients would make Carol Mattix proud and truly continues her commitment to those facing kidney disease and kidney failure," said NKF President Sylvia Rosas, MD, MSCE.
  • In 1999, Wammack lost her father to end-stage kidney disease, which led her to become a dialysis nurse.
  • "I am honored, and in disbelief that the National Kidney Foundation would choose to honor me with the distinguished Carol Mattix Award," Jeanetta said.

Familiarity with GSK's Jesduvroq® (daprodustat) Likely to Be Strong Driver of Adoption in Dialysis, According to Spherix Global Insights

Retrieved on: 
星期一, 三月 27, 2023
Anemia, Epoetin alfa, GSK, Chronic kidney disease, Renal Physicians Association, Food and Drug Administration, Education, Health care, Dialysis, Organization, Medicare, Nephrology, Patient, National Kidney Foundation, FDA, CKD, RealTime, Darbepoetin alfa, Dietary supplement, Pharmaceutical industry, Amgen

EXTON, Pa., March 27, 2023 /PRNewswire/ -- In the 32nd wave of ongoing tracking of the U.S. Renal Anemia market, Spherix surveyed 207 US nephrologists about overall patient management and anticipated treatment changes in the dialysis setting with the launch of GSK's novel HIF-PH inhibitor, Jesduvroq. The survey was fielded in March 2023.

Key Points: 
  • According to Spherix Global Insights, the latest findings from RealTime Dynamix™: Renal Anemia report indicate that the more familiar nephrologists are with Jesduvroq, the more bullish they are about uptake.
  • Spherix Global Insights' latest publication, RealTime Dynamix: Renal Anemia shows that the more familiar nephrologists are with Jesduvroq, the more favorable their impressions of the drug and the more readily they anticipate adoption.
  • Brand Adoption: Those with high familiarity are 6-7 times as likely to prescribe the drug in the next three months compared to those with low familiarity.
  • Spherix will also be tracking key launch performance metrics – including monthly tracking and quarterly deeper quantitative-qualitative analysis through its Launch Dynamix: Jesduvroq® series, kicking off in May 2023.